COMBINED INHIBITION OF TOP1 AND PARP: A NOVEL THERAPEUTIC STRATEGY FOR GBM WITH PTEN DEFICIENCY

被引：0

作者：

Kim, Olga ^{[1
]}

Butler, Madison ^{[2
]}

Robey, Robert ^{[2
]}

Chari, Raj ^{[3
]}

Sergi, Zach ^{[4
]}

Zhang, Meili ^{[3
]}

Pang, Ying ^{[4
]}

Yu, Guangyang ^{[3
]}

Zhang, Wei ^{[3
]}

Song, Hua ^{[3
]}

Davis, Dionne ^{[3
]}

Wang, Herui ^{[4
]}

Merchant, Mythili ^{[4
]}

Ranjan, Alice ^{[4
]}

Gilbert, Mark ^{[1
]}

Gottesman, Michael ^{[3
]}

Pommier, Yves ^{[5
]}

Wu, Jing ^{[1
]}

机构：

[1] NCI, NIH, Neurooncol Branch, Bethesda, MD USA

[2] NCI, NIH, Bethesda, MD USA

[3] NIH, Bethesda, MD USA

[4] NCI, NOB, Bethesda, MD USA

[5] NCI, Bethesda, MD USA

来源：

NEURO-ONCOLOGY | 2022年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

EXTH-63

引用

页码：223 / 223

页数：1

共 50 条

[41] A Novel Therapeutic Strategy Against MYCN-Amplified Neuroblastoma by Chemical-Induced Copy Number Reduction Combined with PARP Inhibitors
Takatori, Atsushi
Yoda, Hiroyuki
Watanabe, Takayoshi
Shinozaki, Yoshinao
Nagase, Hiroki
PEDIATRIC BLOOD & CANCER, 2020, 67
[42] Targeting TRIBBLES1 (TRIB1) Pseudokinase in GBM: A New Therapeutic Strategy
Singh, K.
Fleming, J.
Han, C.
Cui, T.
Johnson, B.
McElroy, J.
Bell, E. H.
Robe, P.
Haque, S. J.
Chakravarti, A.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E512 - E512
[43] Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma
Chila, Rosaria
Basana, Alessandra
Lupi, Monica
Guffanti, Federica
Gaudio, Eugenio
Rinaldi, Andrea
Cascione, Luciano
Restelli, Valentina
Tarantelli, Chiara
Bertoni, Francesco
Damia, Giovanna
Carrassa, Laura
ONCOTARGET, 2015, 6 (05) : 3394 - 3408
[44] JQ1, a Potential Therapeutic Molecule for Myeloid Leukemia with PTEN Deficiency
Baltz, Nicholas J.
Colorado, Natalia C.
Yan, Yan
Lensing, Shelly
Robinson, Delli
Cottler-Fox, Michele H.
Farrar, Jason E.
Emanuel, Peter Dean
Liu, Y. Lucy
BLOOD, 2016, 128 (22)
[45] Poly(ADP-ribose) Polyremase-1 (PARP-1) Inhibition: A Promising Therapeutic Strategy for ETS-Expressing Tumours
Legrand, Arnaud J.
Choul-li, Souhaila
Villeret, Vincent
Aumercier, Marc
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
[46] Can Nimesulide Nanoparticles Be a Therapeutic Strategy for the Inhibition of the KRAS/PTEN Signaling Pathway in Pancreatic Cancer?
Ferreira, Roseane Guimaraes
Mosquera Narvaez, Luis Eduardo
Monteiro Espindola, Kaio Murilo
Rosario, Amanda Caroline R. S.
Lima, Wenddy Graziela N.
Monteiro, Marta Chagas
FRONTIERS IN ONCOLOGY, 2021, 11
[47] PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma
Brenner, J. Chad
Feng, Felix Y.
Han, Sumin
Patel, Sonam
Goyal, Siddharth V.
Bou-Maroun, Laura M.
Liu, Meilan
Lonigro, Robert
Prensner, John R.
Tomlins, Scott A.
Chinnaiyan, Arul M.
CANCER RESEARCH, 2012, 72 (07) : 1608 - 1613
[48] mTOR inhibition as a novel gene therapeutic strategy for diabetic retinopathy
Lee, Steven Hyun Seung
Lee, Joo Yong
Choi, Jun-Sub
Kim, Hee Jong
Kim, Jin
Cha, Seho
Lee, Kyoung Jin
Woo, Ha-Na
Park, Keerang
Lee, Heuiran
PLOS ONE, 2022, 17 (06):
[49] Beta-catenin inhibition as a novel therapeutic strategy for porphyria
Balogun, Anu
Cornuet, Pamela
Nejak-Bowen, Kari
FASEB JOURNAL, 2022, 36
[50] Glutamate carboxypeptidase II (NAALADase) inhibition as a novel therapeutic strategy
Thomas, AG
Wozniak, KM
Tsukamoto, T
Calvin, D
Wu, Y
Rojas, C
Vornov, J
Slusher, BS
N-ACETYLASPARTATE: A UNIQUE NEURONAL MOLECULE IN THE CENTRAL NERVOUS SYSTEM, 2006, 576 : 327 - 337

← 1 2 3 4 5 →